Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BridgeBio Pharma, Inc. (BBIO) vs BioMarin Pharmaceutical Inc. (BMRN)

BridgeBio Pharma, Inc. and BioMarin Pharmaceutical Inc. are both Biotechnology companies. BridgeBio Pharma, Inc. and BioMarin Pharmaceutical Inc. are of similar size ($13.1B and $12.0B). BridgeBio Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; BioMarin Pharmaceutical Inc. trades at 159×. BridgeBio Pharma, Inc. grew revenue faster over the last twelve months: 202.4% against 11.2%. BioMarin Pharmaceutical Inc. has the higher net margin (2.14% vs −97.0%) and the higher return on invested capital (0.97% vs 0.00%). Across the 18 metrics below, BioMarin Pharmaceutical Inc. leads on 11 and BridgeBio Pharma, Inc. on 7.

Valuation

Metric BBIO BMRN Biotechnology median
P/E n/m 158.58 7.88
P/S 18.00 3.42 11.47
P/B n/m 1.84 2.52
Price to free cash flow n/m 16.08 21.16
EV/EBITDA n/m 50.32 0.74
EV/Sales 19.70 4.39 10.73
Earnings yield (5.45%) 0.63% (28.84%)
Free cash flow yield (3.46%) 6.22% (23.03%)

Profitability

Metric BBIO BMRN Biotechnology median
Gross margin 94.44% 76.12% 65.16%
Operating margin (69.81%) 4.38% 0.00%
Net margin (97.03%) 2.14% 0.00%
Free cash flow margin (61.06%) 21.28% 0.00%
Return on equity 32.31% 1.18% (57.72%)
Return on assets (60.23%) 0.76% (49.22%)
Return on invested capital 0.00% 0.97% 0.00%

Growth

Metric BBIO BMRN Biotechnology median
Revenue growth (TTM) 202.39% 11.20% 5.64%
EPS growth (last fiscal year) (31.25%) (18.55%) —
Revenue growth, 5-year CAGR 127.44% 11.60% 8.40%
Net income growth, 5-year CAGR 0.00% (16.39%) 0.00%

Health

Metric BBIO BMRN Biotechnology median
Debt to equity (0.77) 0.66 0.00
Current ratio 1.23 2.39 4.73
Net debt to EBITDA (2.47) (1.99) 0.96

Dividend

Metric BBIO BMRN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BBIO BMRN Biotechnology median
Market cap 13.10b 11.96b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack